Experimental drug shows promise in reversing memory loss for early Alzheimer’s patients

by

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has the potential to restore memory and cognitive function in a mouse model of Alzheimer’s disease.

Leave A Comment

Your email address will not be published. Required fields are marked *